Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

EURORDIS recognises Orphan Europe and Swedish Orphan Biovitrum (SOBI) with awards

Authored by Karl Simpson EURORDIS (European Organisation for Rare Diseases) has handed two prestigious accolades to two European companies at the very heart of rare diseases drug development. Orphan Europe, based in Paris and part of the Recordati Group, was … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , | Leave a comment

Novimmune sees immunotherapy and orphan focus attract new capital

Authored by Karl Simpson Geneva’s biotech cluster has been somewhat tumultuous in recent years . Firstly, Merck Serono decided to close its site in Geneva at a cost of many hundreds of jobs. This was Shire’s gain as they decided … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

UK immunotherapy biotech gains orphan drug designation from FDA

Authored by Karl Simpson Cancer immunotherapy is a hot topic and is in the cross-hairs of many investors and pharma companies. UK biotech, Scancell Holdings, is developing novel immunotherapies for the treatment of cancer based on ImmunoBody® and Moditope®, the … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , | Leave a comment

David Roth appointed Chief Medical Officer of Infinity

Authored by Karl Simpson Dr. David Roth was appointed to Infinity Pharmaceuticals Inc. in 2013 as Senior Vice President of Clinical Development and Medical Affairs, now he will fulfil the role of Chief Medical Officer after being promoted to the … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Karolinska Development announces new Chief Financial Officer

Authored by Karl Simpson Stockholm based Karolinska Development has announced the appointment of Christian Tange as their new Chief Financial Officer, replacing Robin Wright who will leave the company at the end of the month to fulfil a new role … Continue reading

Posted in Executive Appointments, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

BioBlast founders ramp towards another IPO for rare disease company

Authored by Karl Simpson BioBlast Pharma is another rare disease therapeutics company shaping up for an IPO. The Israeli start-up is developing drug therapies for Oculopharyngeal Muscular Dystrophy (OMPD), Machado Joseph Disease and Kennedy’s disease. The company’s lead product is … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , | Leave a comment

New Enterprise Associates backs veteran rare diseases executive team

Authored by Karl Simpson New Enterprise Associates (NEA) has been showing its increasing appetite for rare disease investments as it puts it recent fund to work. With money already invested in companies like Cydan Corporation (led by Cristina Csimma), KLS … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Kiadis rides high after positive clinical data

Authored by James Sheppard The Dutch biotechnology company Kiadis Pharma is continuing on its positive trajectory following the release of positive phase II clinical update for lead asset ATIR. Initial top line data for the trial is expected to be … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Biosimilars – is global development a reality?

Dr Narayanan is the Managing Director of Biologicals Advice Limited. He offers independent advice on all aspects of medicine development with special expertise on biologicals, advanced therapies and biosimilars. He qualified as a medical doctor and subsequently obtained post-graduate qualifications in … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Amal Therapeutics raises seed funding for cancer immunotherapy

Authored by James Sheppard Amal Therapeutics, a biotechnology company co-located between Geneva and Berlin, has raised an undisclosed amount of seed funding. The funds will be used to consolidate the cell penetrating peptide based technology platform and progress the first … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap